Josh Hamermesh has over 15 years of operating, start up, and consulting experience in the life sciences industry. He is currently a vice president at Locust Walk Partners, a transaction advisory firm. Previously, Hamermesh was vice president, Business & Corporate Development at Infinity Pharmaceuticals, where he was responsible for the company’s in-licensing, out-licensing and alliance management activities. Prior to Infinity, he held the position of senior vice president, Strategy & Corporate Development at Pervasis Therapeutics, where he led strategic partnering initiatives for the company’s product development portfolio. Hamermesh also served as vice president, Commercial & Business Development at Molecular Insight Pharmaceuticals, where he completed multiple in-licensing transactions and supported the company’s initial public offering. His biotech career began at Genzyme, where he served as chief operating officer of MG Biotherapeutics, a joint venture with Medtronic, after holding positions of increasing responsibility in marketing and business development. He holds a B.A., magna cum laude, from Amherst College and an M.B.A. from Harvard Business School.